Roflumilast Catalog No.:M8517-10 Inhibition of the cardiac ATP-dependent

Inhibition of the cardiac ATP-dependent potassium current by KB-R7943

Epub 2013 Mar 29

1401242-74-7

Most phosphorylation events downstream of Syk are inhibited with similar potency by R112

Isoprenaline hydrochloride is a non-selective β-adrenergic receptor agonist with potent peripheral vasodilator

Roflumilast Catalog No.:M8517-10 Inhibition of the cardiac ATP-dependentRoflumilast is a drug which acts as a selective, long acting inhibitor of the enzyme PDE 4. It has anti inflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such as asthma, and chronic obstructive pulmonary disease (COPD). In June 2010, Daxas was approved in the EU for severe COPD associated with chronic bronchitis.[9] In March 2011, Daliresp gained FDA approval in the